Pain Wizard topical pain relief recalled for out-of-specification manufacturing
ARG Laboratories recalls Pain Wizard pain relief cream nationwide due to manufacturing defect involving propylene glycol that did not meet specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing quality control issue with out-of-specification propylene glycol. The source does not report any associated illnesses or injuries, and the recall is precautionary in nature.
Plain-English summary
ARG Laboratories, Inc. is recalling Pain Wizard, a topical pain relief product, due to a manufacturing quality control issue. The product is a topical cream in 8 oz tubes containing Camphor 3%, Menthol 3%, Capsaicin, and MSM for muscular and arthritic pain relief.
The manufacturer determined that propylene glycol used in the manufacturing process was a violative grade that did not meet established pharmaceutical specifications. The recall affects 7,410 units distributed nationwide in the United States. The affected product has lot codes 19823C4 (expiration 07/31/2025) and 01623C1 (expiration 01/31/2025).
The recalled product
- Product
- Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin, Camphor, Menthol & MSM, Tube, NET WT 8 oz (226.79g), Made in the USA, painwizard.com PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00011 6
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical Pain Relief
- Hazard
- manufacturing-defect
- quality-control-issue
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots 19823C4
- EXP 07/31/2025
- 01623C1
- Exp 01/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27